Sanjay Awasthi
Overview
Explore the profile of Sanjay Awasthi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
152
Citations
3464
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Krishna B, Ramisetty S, Garg P, Mohanty A, Wang E, Horne D, et al.
Carcinogenesis
. 2024 Jul;
45(9):696-707.
PMID: 39051454
Ral-binding/interacting protein (RLIP) acts as a transporter that responds to stress and provides protection, specifically against glutathione-electrophile conjugates and xenobiotic toxins. Its increased presence in malignant cells, especially in cancer,...
2.
Ramisetty S, Garg P, Mohanty A, Mirzapoiazova T, Yue E, Wang E, et al.
Biochem Pharmacol
. 2023 Oct;
217:115847.
PMID: 37804871
Ovarian cancer (OC) is the most prevalent and deadly cancer of the female reproductive system. Women will continue to be impacted by OC-related morbidity and mortality. Despite the fact that...
3.
Garg P, Awasthi S, Horne D, Salgia R, Singhal S
Biochim Biophys Acta Rev Cancer
. 2023 Jun;
1878(4):188929.
PMID: 37286146
Gynecologic cancers can make up the bulk of cancers in both humans and animals. The stage of diagnosis and the type of tumor, its origin, and its spread are a...
4.
Boulter A, Maurer B, Pogue M, Kang M, Cho H, Knight A, et al.
Cancer Chemother Pharmacol
. 2023 May;
92(2):97-105.
PMID: 37199745
Purpose: Fenretinide (4-HPR) is a synthetic retinoid that induces cytotoxicity through dihydroceramide production. Safingol, a stereochemical-variant dihydroceramide precursor, exhibits synergistic effects when administered with fenretinide in preclinical studies. We conducted...
5.
Kopel J, Singh S, Hindle A, Quirch M, Bose C, Awasthi S
J Community Hosp Intern Med Perspect
. 2023 Feb;
12(6):89-94.
PMID: 36816155
On January 30, 2020, the COVID-19 epidemic was declared an international public health emergency by the World Health Organization. Given the growing impact of the pandemic, there is great interest...
6.
Garg P, Garg R, Horne D, Awasthi S, Salgia R, Singhal S
Cancer Lett
. 2023 Feb;
557:216079.
PMID: 36736532
Cancer is a pervasive, constantly evolving, and significant public health concern. The number of new cancer cases has risen dramatically in the last decades, making it one of the top...
7.
Singhal S, Garg R, Horne D, Singhal S, Awasthi S, Salgia R
Biochim Biophys Acta Rev Cancer
. 2022 Sep;
1877(5):188803.
PMID: 36150564
Previously, we showed that knockout mice homozygous for deficiency of the mercapturic acid pathway (MAP) transporter protein, RLIP (RLIP), are resistant to chemical carcinogenesis, inflammation, and metabolic syndrome (MetS). We...
8.
Nagaprashantha L, Singhal J, Li H, Warden C, Liu X, Horne D, et al.
Oncotarget
. 2022 Mar;
13:331.
PMID: 35261722
[This corrects the article DOI: 10.18632/oncotarget.24720.].
9.
Lloyd N, Kopel J, Awasthi S, Cordero J
Mol Clin Oncol
. 2022 Mar;
16(3):73.
PMID: 35251624
Aggressive fibromatosis (AF) is a rare, benign neoplasm originating from musculoaponeurotic stromal structures characterized by aggressive growth and infiltration of local tissues. To date, only six previous cases of AF...
10.
Hindle A, Bose C, Lee J, Palade P, Peterson C, Reddy P, et al.
Cancers (Basel)
. 2022 Feb;
14(3).
PMID: 35158795
Rlip76 (Rlip) is a multifunctional membrane protein that facilitates the high metabolic rates of cancer cells through the efflux of toxic metabolites and other functions. Rlip inhibition or depletion results...